Startups

TTTTT

Our startups

Be inspired. Search our startups.

Filter
Gold Winners
2017 Boston Gold Winner

There is a crisis in medical imaging. Current MRI contrast agents (GBCAs) contain toxic gadolinium. GBCAs cause brain deposition of gadolinium in all patients, and pose devastating risks to renally impaired patients. Each year over 4 million very sick patients worldwide must be denied crucial diagnostic imaging, and over 30 million patients are put at risk.
Reveal solves this >$1B problem with a biocompatible gadolinium-free contrast agent that is a safe, direct substitute for GBCAs.

Silver Winners
2017 Boston Silver Winner

47% of all dogs over the age of 10 will die from cancer. With current treatment options expensive and potentially leading to negative side effects, VetiVax is a novel, personalized immunotherapy that uses the animals’ own tumor cells to fight the cancer.

Using a surgically excised portion of tumor tissue, we create a series of treatments that are given back to the animal to help stimulate their immune system to fight cancer, safely and inexpensively.

2017 Boston Silver Winner

ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites. ReviveMed technology, which was developed at MIT and published in Nature Methods, uniquely overcomes the difficulty of using a large set of metabolomic data, and transform these data into actionable insight. Currently, we selected a few strategic clients from leading pharma/biotech companies to provide them with drug de-risking, biomarker discovery and therapeutic solutions.

Startups
2017 Boston Silver Winner

47% of all dogs over the age of 10 will die from cancer. With current treatment options expensive and potentially leading to negative side effects, VetiVax is a novel, personalized immunotherapy that uses the animals’ own tumor cells to fight the cancer.

Using a surgically excised portion of tumor tissue, we create a series of treatments that are given back to the animal to help stimulate their immune system to fight cancer, safely and inexpensively.

2017 Boston Silver Winner

ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites. ReviveMed technology, which was developed at MIT and published in Nature Methods, uniquely overcomes the difficulty of using a large set of metabolomic data, and transform these data into actionable insight. Currently, we selected a few strategic clients from leading pharma/biotech companies to provide them with drug de-risking, biomarker discovery and therapeutic solutions.

2017 Boston Gold Winner

There is a crisis in medical imaging. Current MRI contrast agents (GBCAs) contain toxic gadolinium. GBCAs cause brain deposition of gadolinium in all patients, and pose devastating risks to renally impaired patients. Each year over 4 million very sick patients worldwide must be denied crucial diagnostic imaging, and over 30 million patients are put at risk.
Reveal solves this >$1B problem with a biocompatible gadolinium-free contrast agent that is a safe, direct substitute for GBCAs.